Dr. Alejando Sweet-Cordero cares for children with cancer. He specializes in treating patients with sarcomas (a type of cancer that originates in bone or soft tissue) and in treating advanced cancers through precision medicine (the use of a patient's genetic data to optimize therapy).
In research, Sweet-Cordero has two areas of focus. First, he studies ways to use gene sequencing data from tumors to inform treatment decisions. Specifically, he directs the UCSF Molecular Oncology Initiative, which uses such data in determining the best treatments for relapsed, growing or other difficult-to-treat cases. Second, he runs a research lab dedicated to finding new therapies for sarcomas, particularly osteosarcoma and Ewing's sarcoma.
Sweet-Cordero earned his medical degree at UCSF, where he also completed a residency in pediatrics. He completed a fellowship in pediatric oncology at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
A native Spanish speaker, Sweet-Cordero enjoys working with Spanish-speaking patients and their families. He appreciates the diversity of UCSF's patient population and how it reflects the Bay Area's cultural diversity. In his free time, he enjoys spending time with family and friends, cooking and reading.